Rebecca Taub
2016
In 2016, Rebecca Taub earned a total compensation of $1.7M as Chief Medical Officer, Executive Vice President, Research & Development at Synta Pharmaceuticals.
Compensation breakdown
| Bonus | $62,160 |
|---|---|
| Option Awards | $1,139,272 |
| Salary | $162,705 |
| Stock Awards | $289,416 |
| Other | $465 |
| Total | $1,654,018 |
Taub received $1.1M in option awards, accounting for 69% of the total pay in 2016.
Taub also received $62.2K in bonus, $162.7K in salary, $289.4K in stock awards and $465 in other compensation.
Rankings
In 2016, Rebecca Taub's compensation ranked 5,791st out of 14,075 executives tracked by ExecPay. In other words, Taub earned more than 58.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,791 out of 14,075 | 59th |
Division Manufacturing | 2,102 out of 5,489 | 62nd |
Major group Chemicals And Allied Products | 684 out of 1,895 | 64th |
Industry group Drugs | 513 out of 1,538 | 67th |
Industry Pharmaceutical Preparations | 408 out of 1,176 | 65th |
Source: SEC filing on April 27, 2018.
Taub's colleagues
We found two more compensation records of executives who worked with Rebecca Taub at Synta Pharmaceuticals in 2016.